Alnylam Pharmaceuticals (ALNY) Stock Chart & Stock Price History → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free ALNY Stock Alerts $143.31 -0.40 (-0.28%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Alnylam Pharmaceuticals Stock Price Performance5 Day Performance-1.70%1 Month Performance-7.18%3 Month Performance-20.21%6 Month Performance-5.57%Year-To-Date Performance-25.13%1 Year Performance-26.90% Receive ALNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> ALNY Stock Chart for Saturday, April, 27, 2024 ALNY Chart by TradingView Alnylam Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$143.71$143.31-0.28%$146.07$143.00479,138 shs$18.05 billion04/25/2024$143.80$143.71-0.06%$145.79$141.98489,263 shs$18.10 billion04/24/2024$146.07$143.80-1.55%$147.49$143.52395,369 shs$18.11 billion04/23/2024$145.79$146.07+0.19%$150.27$145.04543,726 shs$18.40 billion04/22/2024$144.41$145.79+0.96%$147.86$143.69399,984 shs$18.36 billion04/19/2024$145.16$144.41-0.52%$146.92$143.51703,168 shs$18.19 billion Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$145.32$145.16-0.11%$146.45$144.50398,901 shs$18.28 billion04/17/2024$146.72$145.32-0.95%$147.49$145.19601,282 shs$18.30 billion04/16/2024$147.70$146.72-0.66%$148.44$146.01352,424 shs$18.48 billion04/15/2024$148.50$147.70-0.54%$150.37$146.73498,935 shs$18.60 billion04/12/2024$152.09$148.50-2.36%$151.80$148.28427,819 shs$18.70 billion04/11/2024$152.41$152.09-0.21%$154.02$149.93473,409 shs$19.16 billion04/10/2024$155.90$152.41-2.24%$154.96$151.91571,298 shs$19.20 billion04/09/2024$156.04$155.90-0.09%$159.34$154.89595,956 shs$19.64 billion04/08/2024$153.56$156.04+1.62%$157.96$153.25738,213 shs$19.65 billion04/05/2024$151.48$153.56+1.37%$154.00$149.41351,489 shs$19.34 billion04/04/2024$150.83$151.48+0.43%$154.34$150.81531,882 shs$19.08 billion04/03/2024$151.04$150.83-0.14%$151.27$149.25315,048 shs$19.00 billion04/02/2024$153.33$151.04-1.49%$152.27$150.67445,640 shs$19.02 billion04/01/2024$149.45$153.33+2.60%$154.20$147.58523,250 shs$19.31 billion03/29/2024$149.45$149.45$154.50$149.32666,592 shs$18.82 billion03/28/2024$154.39$149.45-3.20%$154.50$149.32666,576 shs$18.82 billion03/27/2024$151.97$154.39+1.59%$155.28$150.40463,043 shs$19.45 billion03/26/2024$152.07$151.97-0.07%$153.43$150.81532,230 shs$19.14 billion03/25/2024$146.51$152.07+3.79%$152.63$147.13799,298 shs$19.15 billion03/22/2024$146.62$146.51-0.08%$147.10$143.66834,175 shs$18.45 billion03/21/2024$147.99$146.62-0.93%$150.68$145.41611,511 shs$18.47 billion03/20/2024$148.17$147.99-0.12%$148.64$145.22439,772 shs$18.64 billion03/19/2024$147.41$148.17+0.52%$149.69$146.00517,163 shs$18.66 billion03/18/2024$149.27$147.41-1.25%$151.00$147.22460,718 shs$18.57 billion03/15/2024$148.53$149.27+0.50%$150.09$145.54905,205 shs$18.80 billion03/14/2024$148.42$148.53+0.07%$149.59$145.77505,840 shs$18.71 billion03/13/2024$146.65$148.42+1.21%$151.46$146.82858,993 shs$18.69 billion03/12/2024$149.10$146.65-1.64%$150.02$146.61683,429 shs$18.47 billion03/11/2024$149.82$149.10-0.48%$152.50$148.88661,992 shs$18.78 billion03/08/2024$149.86$149.82-0.03%$152.88$149.14637,629 shs$18.87 billion03/07/2024$149.66$149.86+0.13%$150.56$149.24563,928 shs$18.87 billion03/06/2024$149.68$149.66-0.01%$150.24$147.63521,529 shs$18.85 billion03/05/2024$150.04$149.68-0.24%$151.21$147.52620,483 shs$18.85 billion03/04/2024$152.61$150.04-1.68%$154.85$149.89950,685 shs$18.90 billionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$151.09$152.61+1.01%$155.91$150.00523,455 shs$19.22 billion02/29/2024$155.23$151.09-2.67%$157.52$149.001.81 million shs$19.03 billion02/28/2024$159.00$155.23-2.37%$158.90$153.941.26 million shs$19.55 billion02/27/2024$158.66$159.00+0.21%$161.31$157.91674,827 shs$20.03 billion02/26/2024$157.65$158.66+0.64%$159.04$153.94556,235 shs$19.98 billion02/23/2024$162.81$157.65-3.17%$163.01$155.821.48 million shs$19.86 billion02/22/2024$154.74$162.81+5.22%$164.02$154.031.17 million shs$20.51 billion02/21/2024$149.69$154.74+3.37%$155.38$148.843.66 million shs$19.49 billion02/20/2024$147.00$149.69+1.83%$150.06$145.811.29 million shs$18.85 billion02/19/2024$147.00$147.00$150.93$146.821.89 million shs$18.51 billion02/16/2024$147.43$147.00-0.29%$150.93$146.821.89 million shs$18.45 billion02/15/2024$164.15$147.43-10.19%$153.27$143.525.43 million shs$18.50 billion02/14/2024$162.00$164.15+1.33%$164.63$161.51931,439 shs$20.60 billion02/13/2024$169.34$162.00-4.33%$166.50$160.84800,278 shs$20.33 billion02/12/2024$170.03$169.34-0.41%$171.57$166.87782,411 shs$21.25 billion02/09/2024$169.50$170.03+0.31%$171.86$168.54481,037 shs$21.34 billion02/08/2024$168.60$169.50+0.53%$170.25$165.591.61 million shs$21.27 billion02/07/2024$172.18$168.60-2.08%$172.55$167.43771,746 shs$21.16 billion02/06/2024$170.70$172.18+0.87%$173.18$169.811.44 million shs$21.61 billion02/05/2024$173.06$170.70-1.36%$172.73$168.00602,382 shs$21.42 billion02/02/2024$174.92$173.06-1.06%$174.48$169.32639,127 shs$21.72 billion02/01/2024$172.91$174.92+1.16%$176.35$172.21624,761 shs$21.95 billion01/31/2024$180.12$172.91-4.00%$179.80$172.37836,469 shs$21.70 billion01/30/2024$180.96$180.12-0.46%$181.66$178.36475,718 shs$22.60 billion01/29/2024$179.62$180.96+0.75%$181.50$176.121.04 million shs$22.71 billion01/26/2024$183.93$179.62-2.34%$184.29$179.47517,399 shs$22.54 billion Related Companies: BioMarin Pharmaceutical Stock Price Chart Royalty Pharma Stock Price Chart United Therapeutics Stock Price Chart Ionis Pharmaceuticals Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Genmab A/S Stock Price Chart Teva Pharmaceutical Industries Stock Price Chart Viatris Stock Price Chart BeiGene Stock Price Chart Karuna Therapeutics Stock Price Chart Receive ALNY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALNY) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.